Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage.
暂无分享,去创建一个
R. Tuan | L. Shum | G. Nuckolls | P. Manner | A. Horner | Xibin Wang
[1] S. K. Zaidi,et al. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression , 2004, Oncogene.
[2] H. Yatani,et al. Cbfa1/Runx2 gene expression in articular chondrocytes of the mice temporomandibular and knee joints in vivo. , 2003, Archives of oral biology.
[3] Tomoyuki Saito,et al. Fibroblast growth factor 2 in synovial fluid from an osteoarthritic knee with cartilage regeneration , 2003, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.
[4] B. Riggs,et al. Changes in Runx2/Cbfa1 Expression and Activity During Osteoblastic Differentiation of Human Bone Marrow Stromal Cells , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] H. Ryoo,et al. The Protein Kinase C Pathway Plays a Central Role in the Fibroblast Growth Factor-stimulated Expression and Transactivation Activity of Runx2* , 2003, The Journal of Biological Chemistry.
[6] T. Aigner,et al. Quantification of expression levels of cellular differentiation markers does not support a general shift in the cellular phenotype of osteoarthritic chondrocytes , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[7] G. Stein,et al. Cbfβ interacts with Runx2 and has a critical role in bone development , 2002, Nature Genetics.
[8] G. Stein,et al. The core-binding factor β subunit is required for bone formation and hematopoietic maturation , 2002, Nature Genetics.
[9] T. Fujita,et al. Core-binding factor β interacts with Runx2 and is required for skeletal development , 2002, Nature Genetics.
[10] A R Poole,et al. Type II collagen degradation and its regulation in articular cartilage in osteoarthritis , 2002, Annals of the rheumatic diseases.
[11] T. Aigner,et al. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. , 2002, Arthritis and rheumatism.
[12] Yoshiaki Ito,et al. Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms , 2002, EMBO reports.
[13] G. Xiao,et al. Fibroblast Growth Factor 2 Induction of the Osteocalcin Gene Requires MAPK Activity and Phosphorylation of the Osteoblast Transcription Factor, Cbfa1/Runx2* , 2002, The Journal of Biological Chemistry.
[14] T. Aigner,et al. Apoptosis and cellular vitality: issues in osteoarthritic cartilage degeneration. , 2002, Arthritis and rheumatism.
[15] E. Arner. Aggrecanase-mediated cartilage degradation. , 2002, Current opinion in pharmacology.
[16] R. Wait,et al. Basic FGF mediates an immediate response of articular cartilage to mechanical injury , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Mundlos,et al. Role of Runx genes in chondrocyte differentiation. , 2002, Developmental biology.
[18] H. V. Van Wart,et al. Proteolysis Involving Matrix Metalloproteinase 13 (Collagenase‐3) Is Required for Chondrocyte Differentiation That Is Associated with Matrix Mineralization , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] G. Karsenty,et al. Physical Interaction of the Activator Protein-1 Factors c-Fos and c-Jun with Cbfa1 for Collagenase-3 Promoter Activation* , 2002, The Journal of Biological Chemistry.
[20] C. Brinckerhoff,et al. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors , 2001, Arthritis Research & Therapy.
[21] Glen Nuckolls,et al. The life cycle of chondrocytes in the developing skeleton , 2001, Arthritis research.
[22] C. López-Otín,et al. A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation , 2001, The Journal of cell biology.
[23] N. Fukui,et al. Cell biology of osteoarthritis: The chondrocyte’s response to injury , 2001, Current rheumatology reports.
[24] B. Swoboda,et al. Expression of early and late differentiation markers (proliferating cell nuclear antigen, syndecan-3, annexin VI, and alkaline phosphatase) by human osteoarthritic chondrocytes. , 2001, The American journal of pathology.
[25] C. Brinckerhoff,et al. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways. , 2001, Nucleic acids research.
[26] C. Hartmann,et al. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2 , 2001, Mechanisms of Development.
[27] P. Angel,et al. AP-1 and Cbfa/Runt Physically Interact and Regulate Parathyroid Hormone-dependent MMP13 Expression in Osteoblasts through a New Osteoblast-specific Element 2/AP-1 Composite Element* , 2001, The Journal of Biological Chemistry.
[28] T. Pufe,et al. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. , 2001, Arthritis and rheumatism.
[29] N. Kanatani,et al. Skeletal Malformations Caused by Overexpression of Cbfa1 or Its Dominant Negative Form in Chondrocytes , 2001, The Journal of cell biology.
[30] B. Swoboda,et al. Type IIA procollagen: Expression in developing chicken limb cartilage and human osteoarthritic articular cartilage , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.
[31] S. Takeda,et al. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. , 2001, Genes & development.
[32] A. Poole,et al. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. , 2001, The Journal of clinical investigation.
[33] J. Compston,et al. Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone. , 2001, Bone.
[34] N. Selvamurugan,et al. Developmental Regulation of Collagenase-3 mRNA in Normal, Differentiating Osteoblasts through the Activator Protein-1 and therunt Domain Binding Sites* , 2000, The Journal of Biological Chemistry.
[35] E. Canalis,et al. Basic fibroblast growth factor stimulates collagenase-3 promoter activity in osteoblasts through an activator protein-1-binding site. , 2000, Endocrinology.
[36] Y. Kitamura,et al. Cbfa1 Is a Positive Regulatory Factor in Chondrocyte Maturation* , 2000, The Journal of Biological Chemistry.
[37] D. Tyson,et al. Parathyroid Hormone Regulation of the Rat Collagenase-3 Promoter by Protein Kinase A-dependent Transactivation of Core Binding Factor α1* , 2000, The Journal of Biological Chemistry.
[38] H. Madry,et al. Efficient lipid-mediated gene transfer to articular chondrocytes , 2000, Gene Therapy.
[39] J. Pelletier,et al. Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiologic state of the cells. , 1999, Arthritis and rheumatism.
[40] C. López-Otín,et al. Collagenase 3 Is a Target of Cbfa1, a Transcription Factor of the runt Gene Family Involved in Bone Formation , 1999, Molecular and Cellular Biology.
[41] S. Nomura,et al. Maturational disturbance of chondrocytes in Cbfa1‐deficient mice , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.
[42] P. Angel,et al. Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone , 1999, Oncogene.
[43] C. López-Otín,et al. Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. , 1998, The American journal of pathology.
[44] N. Selvamurugan,et al. Parathyroid Hormone Regulates the Rat Collagenase-3 Promoter in Osteoblastic Cells through the Cooperative Interaction of the Activator Protein-1 Site and the runt Domain Binding Sequence* , 1998, The Journal of Biological Chemistry.
[45] G. Karsenty,et al. Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.
[46] C. López-Otín,et al. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[47] C. Rorabeck,et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. , 1997, The Journal of clinical investigation.
[48] J. Heino,et al. Collagenase‐3 (MMP‐13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.
[49] R. Heller,et al. Cytokine Control of Interstitial Collagenase and Collagenase-3 Gene Expression in Human Chondrocytes* , 1996, The Journal of Biological Chemistry.
[50] E. Wagner,et al. Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[51] G. Karsenty,et al. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene , 1995, Molecular and cellular biology.
[52] B. Vandenbunder,et al. Expression of interstitial collagenase is restricted to skeletal tissue during mouse embryogenesis. , 1995, Journal of cell science.
[53] J. T. Thomas,et al. Distribution of type X collagen mRNA in normal and osteoarthritic human cartilage. , 1991, Bone and mineral.
[54] K. Burridge,et al. Functional studies of the domains of talin , 1990, The Journal of cell biology.